Cytomegalovirus Infection
📧 Sign up to get email alerts when something new happens for Cytomegalovirus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-05-30Clinical Trial Update: Evaluation of the Safety and Immune Responses of the Towne Strain of CMV in Seronegative Women [Phase 2, Phase 3]
This Phase 2/3 trial evaluating the Towne strain CMV vaccine in seronegative women was terminated, with safety and immune response results p…
-
FDA approval · 2016-04-28FDA Approved: VALGANCICLOVIR — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for valganciclovir hydrochloride (valganciclovir) by Strides Pharma Science Limited, a generic versi…
-
CLINICAL_TRIALS trial_result · 2016-04-26Clinical Trial Update: A Retrospective Chart Review Study of Gene-Eden-VIR/Novirin
Completed retrospective chart review evaluating the antiviral supplement Gene-Eden-VIR/Novirin across multiple viral infections to assess ou…
-
FDA approval · 2016-03-18FDA Approved: VALGANCICLOVIR — Original Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals’ original application for valganciclovir, enabling a generic version of the antiviral.
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Inflammation, Infection, and Future Cardiovascular Risk
This is a completed NHLBI clinical trial update examining how inflammation and infection relate to future cardiovascular risk. It discusses …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-02-22Clinical Trial Update: Administration of Virus Specific CTLs for the Prophylaxis and Treatment of EBV/CMV Infections After HSCT in China [Phase 1]
This is a Phase 1 clinical trial in China evaluating virus-specific cytotoxic T lymphocytes to prophylactically prevent and therapeutically …
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Infection and Cardiovascular Disease
Clinical trial update indicating the NHLBI study on infections and cardiovascular disease has completed. The provided excerpt does not inclu…
-
CLINICAL_TRIALS trial_result · 2016-02-08Clinical Trial Update: Clinical Validation of Lophius Biosciences Kit T-Track® CMV in Kidney Transplant Recipients
Completed clinical validation of the T-Track CMV diagnostic kit from Lophius Biosciences in kidney transplant recipients to assess CMV-speci…
-
CLINICAL_TRIALS withdrawal · 2016-01-21Clinical Trial Update: Allogeneic Virus-Specific Cytotoxic T-Lymphocytes(CTL), Persistent/Recurrent Viral Infection Post-HSCT (EAP CHALLAH)
A clinical trial evaluating allogeneic virus-specific cytotoxic T-lymphocytes for persistent or recurrent EBV, CMV, and adenoviral infection…
-
CLINICAL_TRIALS trial_result · 2015-12-16Clinical Trial Update: Transfusion Infections Pediatric Prospective Study (TRIPPS)
A completed pediatric prospective study (TRIPPS) evaluating transfusion infection risks associated with blood donors, including cytomegalovi…
-
CLINICAL_TRIALS research · 2015-11-18Clinical Trial Update: Assessment of CMV-specific ELISPOT Assay for Predicting CMV Infection in Bone Marrow Transplant Recipients (ACE-BMT)
This document reports an update on a clinical trial evaluating a CMV-specific ELISPOT assay to predict cytomegalovirus infection in patients…
-
CLINICAL_TRIALS research · 2015-10-12Clinical Trial Update: The Benefits Feasibility and Acceptability of Extended Screening Testing in Newborn Babies Who Are Referred for Further Hearing Assessment
A completed clinical trial evaluating the feasibility and acceptability of extended newborn screening tests for infants referred for further…
-
CLINICAL_TRIALS trial_result · 2015-09-25Clinical Trial Update: Assessment of CMV-specific ELISPOT Assay for Predicting CMV Infection in Kidney Transplant Recipients
The trial assessed the CMV-specific ELISPOT assay as a predictor of CMV infection in kidney transplant recipients and has completed.
-
FDA approval · 2015-07-14FDA Approved: VALCYTE — Supplemental Application (H2-Pharma, LLC)
FDA approved a supplemental application for VALCYTE (valganciclovir hydrochloride) submitted by H2-Pharma, LLC.
-
CLINICAL_TRIALS withdrawal · 2015-06-08Clinical Trial Update: Autologous Cytomegalovirus (CMV) Specific CD8+ T Cells as Treatment for CMV Reactivation [Phase 1, Phase 2]
A phase 1/2 trial evaluating autologous CMV-specific CD8+ T cells to treat CMV reactivation after allogeneic stem cell transplantation has b…
-
CLINICAL_TRIALS research · 2015-05-22Clinical Trial Update: Review of Human Herpes Viruses in Burns
This completed clinical trial update reviews the involvement of human herpesviruses in burn injuries, focusing on herpes simplex virus, vari…
-
CLINICAL_TRIALS trial_result · 2015-05-19Clinical Trial Update: Safety Study of Four Chimera Cytomegalovirus (CMV) Vaccines in Healthy Adult Males 30-50 Years of Age [Phase 1]
Phase 1 safety study evaluating four chimera cytomegalovirus vaccines in healthy adult males aged 30-50 years; the trial status is completed…
-
FDA approval · 2015-04-23FDA Approved: VALCYTE — Supplemental Application (H2-Pharma, LLC)
FDA approves a supplemental application for VALCYTE (valganciclovir hydrochloride) submitted by H2-Pharma, LLC.
-
FDA approval · 2015-04-23FDA Approved: VALCYTE — Supplemental Application (H2-Pharma, LLC)
FDA approved a supplemental application for VALCYTE (valganciclovir) submitted by H2-Pharma, LLC.
-
CLINICAL_TRIALS trial_result · 2015-04-21Clinical Trial Update: Valganciclovir in Prevention of Cytomegalovirus (CMV) Reactivation Following Allogeneic-Stem Cell Transplantation (SCT) [Phase 3]
A Phase 3 trial evaluating valganciclovir to prevent CMV reactivation after allogeneic stem cell transplantation has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-23Clinical Trial Update: Efficacy and Safety of Induction Strategies Combined With Low Tacrolimus Exposure in Kidney Transplant Recipients Receiving Everolimus or Sodium Mycophenolate [Phase 4]
Phase 4 trial assessing induction strategies with low tacrolimus exposure in kidney transplant patients treated with everolimus or mycopheno…
-
CLINICAL_TRIALS research · 2015-03-23Clinical Trial Update: Natural History of Cytomegalovirus (CMV) Infection and Disease Among Renal Transplant Recipients
This clinical trial update describes the natural history of cytomegalovirus infection and disease in renal transplant recipients.
-
CLINICAL_TRIALS trial_result · 2015-01-12Clinical Trial Update: Cytomegalovirus Control in Critical Care [Phase 2]
Phase 2 trial update on cytomegalovirus control in critically ill patients has completed.
-
CLINICAL_TRIALS research · 2015-01-07Clinical Trial Update: MSC for Treatment of CMV Infection [Phase 2]
Phase 2 clinical trial investigating mesenchymal stem cells to treat cytomegalovirus infection in hematopoietic stem cell transplant patient…
-
CLINICAL_TRIALS trial_result · 2014-12-24Clinical Trial Update: CMV Intensive Care Units
Clinical trial NCT02324244 evaluating cytomegalovirus infection in ICU patients has completed. The snippet does not include trial results.